Literature DB >> 11681210

The application of proteomics in defining the T cell antigens of Mycobacterium tuberculosis.

B A Covert1, J S Spencer, I M Orme, J T Belisle.   

Abstract

The complete sequencing of the Mycobacterium tuberculosis genome offers a unique opportunity to fully elucidate the biology of this human pathogen. One aspect of significant importance is the definition of T cell antigens. This report describes the development and implementation of a proteomic approach to defining such antigens. Large quantities of subcellular protein fractions of M. tuberculosis were resolved by two-dimensional liquid phase electrophoresis (2-D LPE), resulting in 355 and 299 fractions of culture filtrate and cytosolic proteins, respectively. Analysis of these fractions against splenocytes of C57Bl/6 mice infected with M. tuberculosis resulted in the identification of 37 fractions that stimulated a dominant T cell response, as measured by the production of interferon-gamma. Additionally, when the 2-D LPE fractions were assayed against splenocytes harvested at 10 and 40 days post infection significant changes in the T cell response were observed. Molecular characterization of the proteins contained in each of the 38 immunodominant fractions by liquid chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry resulted in the identification of 30 individual proteins. Many of these represented previously defined antigens. However 17 of these proteins were novel T cell antigens. The data presented demonstrate that proteomics offers a rapid and facile approach for elucidation of immunodominant T cell antigens of pathogenic bacteria.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11681210     DOI: 10.1002/1615-9861(200104)1:4<574::AID-PROT574>3.0.CO;2-8

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  34 in total

1.  Lipidomic analyses of Mycobacterium tuberculosis based on accurate mass measurements and the novel "Mtb LipidDB".

Authors:  Mark J Sartain; Donald L Dick; Christopher D Rithner; Dean C Crick; John T Belisle
Journal:  J Lipid Res       Date:  2011-02-01       Impact factor: 5.922

Review 2.  Expression profiling in granulomatous lung disease.

Authors:  Edward S Chen; David R Moller
Journal:  Proc Am Thorac Soc       Date:  2007-01

Review 3.  Interaction between Yersinia pestis and the host immune system.

Authors:  Bei Li; Ruifu Yang
Journal:  Infect Immun       Date:  2008-02-04       Impact factor: 3.441

Review 4.  Antigens for CD4 and CD8 T cells in tuberculosis.

Authors:  Cecilia S Lindestam Arlehamn; David Lewinsohn; Alessandro Sette; Deborah Lewinsohn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-22       Impact factor: 6.915

5.  Peripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in human models of immunity to tuberculosis.

Authors:  Suraj B Sable; Rajnish Kumar; Mamta Kalra; Indu Verma; G K Khuller; Karen Dobos; John T Belisle
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Proteomics in Vaccinology and Immunobiology: An Informatics Perspective of the Immunone.

Authors:  Irini A. Doytchinova; Paul Taylor; Darren R. Flower
Journal:  J Biomed Biotechnol       Date:  2003

7.  Nonclassical transpeptidases of Mycobacterium tuberculosis alter cell size, morphology, the cytosolic matrix, protein localization, virulence, and resistance to β-lactams.

Authors:  Maia K Schoonmaker; William R Bishai; Gyanu Lamichhane
Journal:  J Bacteriol       Date:  2014-01-24       Impact factor: 3.490

8.  Analysis of the secretome and identification of novel constituents from culture filtrate of bacillus Calmette-Guerin using high-resolution mass spectrometry.

Authors:  Jianhua Zheng; Xianwen Ren; Candong Wei; Jian Yang; Yongfeng Hu; Liguo Liu; Xingye Xu; Jin Wang; Qi Jin
Journal:  Mol Cell Proteomics       Date:  2013-04-24       Impact factor: 5.911

9.  Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis.

Authors:  Prashant Sharma; Bhavnesh Kumar; Yash Gupta; Neelja Singhal; Vishwa Mohan Katoch; Krishnamurthy Venkatesan; Deepa Bisht
Journal:  Proteome Sci       Date:  2010-11-18       Impact factor: 2.480

10.  Characterizing the Mycobacterium tuberculosis Rv2707 protein and determining its sequences which specifically bind to two human cell lines.

Authors:  Julie A Chapeton-Montes; David F Plaza; Hernando Curtidor; Martha Forero; Magnolia Vanegas; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  Protein Sci       Date:  2007-12-20       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.